Hemato is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2020. The journal covers Medicine.
Authors are required to pay an article processing charge to publish in Hemato; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Hemato has published 237 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
lymphoid leukemias, immunogenetics, non neoplastic blood disorders, transplantation, target therapy, immunobiology
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2020
- Review time
- 11 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2673-6357
Frequently asked questions
Is Hemato peer-reviewed?
Does Hemato charge an article processing charge (APC)?
What subjects does Hemato publish?
What languages does Hemato accept?
What is the ISSN of Hemato?
2673-6357 (electronic).